The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
High-level nitrofurantoin resistance in a clinical isolate of Klebsiella pneumoniae: a comparative genomics and metabolomics analysis
Open accessAbstract
Nitrofurantoin is a commonly used chemotherapeutic agent in the treatment of uncomplicated urinary tract infections caused by the problematic multidrug resistant Gram-negative pathogen Klebsiella pneumoniae . The present study aims to elucidate the mechanism of nitrofurantoin action and high-level resistance in K. pneumoniae using whole-genome sequencing (WGS), qPCR analysis, mutation structural modeling and untargeted metabolomic analysis. WGS profiling of evolved highly resistant mutants (nitrofurantoin minimum inhibitory concentrations > 256 mg/L) revealed modified expression of several genes related to membrane transport (porin ompK36 and efflux pump regulator oqxR ) and nitroreductase activity ( ribC and nfsB , involved in nitrofurantoin reduction). Untargeted metabolomics analysis of total metabolites extracted at 1 and 4 h post-nitrofurantoin treatment revealed that exposure to the drug caused a delayed effect on the metabolome which was most pronounced after 4 h. Pathway enrichment analysis illustrated that several complex interrelated metabolic pathways related to nitrofurantoin bacterial killing (aminoacyl-tRNA biosynthesis, purine metabolism, central carbohydrate metabolism, and pantothenate and CoA biosynthesis) and the development of nitrofurantoin resistance (riboflavin metabolism) were significantly perturbed. This study highlights for the first time the key role of efflux pump regulator oqxR in nitrofurantoin resistance and reveals global metabolome perturbations in response to nitrofurantoin, in K. pneumoniae . IMPORTANCE: A quest for novel antibiotics and revitalizing older ones (such as nitrofurantoin) for treatment of difficult-to-treat Gram-negative bacterial infections has become increasingly popular. The precise antibacterial activity of nitrofurantoin is still not fully understood. Furthermore, although the prevalence of nitrofurantoin resistance remains low currently, the drug’s fast-growing consumption worldwide highlights the need to comprehend the emerging resistance mechanisms. Here, we used multidisciplinary techniques to discern the exact mechanism of nitrofurantoin action and high-level resistance in Klebsiella pneumoniae , a common cause of urinary tract infections for which nitrofurantoin is the recommended treatment. We found that the expression of multiple genes related to membrane transport (including active efflux and passive diffusion of drug molecules) and nitroreductase activity was modified in nitrofurantoin-resistant strains, including oqxR, the transcriptional regulator of the oqxAB efflux pump. Furthermore, complex interconnected metabolic pathways that potentially govern the nitrofurantoin-killing mechanisms (e.g., aminoacyl-tRNA biosynthesis) and nitrofurantoin resistance (riboflavin metabolism) were significantly inhibited following nitrofurantoin treatment. Our study could help inform the improvement of nitrofuran derivatives, the development of new pharmacophores, or drug combinations to support the resurgence of nitrofurantoin in the management of multidrug resistant K. pneumouniae infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“resistance to this drug has been documented and linked to the efflux pump regulator oqxR [40].”
From Microbiological Quality of Coconut Water Sold in the Grande Vitória Region, Brazil, and Phenogenotypic Antimicrobial Resistance of Associated Enterobacteria (2024) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400 · cited 1×
“2.9 (51) with a sensitive local algorithm and a maximum insert length of 2,000 bp, and variant sites are called with SAMtools v1.”
MethodInfluentialProkka: rapid prokaryotic genome annotation
Seemann, T. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu153 · Cited by 18,818
Wiegand, I., Hilpert, K., & Hancock, R. E. W. (2008) · Nature Protocols · doi:10.1038/nprot.2007.521 · Cited by 6,156
KEGG for integration and interpretation of large-scale molecular data sets
Kanehisa, M., Goto, S., Sato, Y., Furumichi, M., & Tanabe, M. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr988 · Cited by 4,848 · cited 1×
“Metabolic pathway analysis was performed for the statistically significant identified metabolites using KEGG Mapper (64).”
MethodArtemis: sequence visualization and annotation
Rutherford, K., Parkhill, J., Crook, J., Horsnell, T., Rice, P., Rajandream, M.-A., & Barrell, B. (2000) · Bioinformatics · doi:10.1093/bioinformatics/16.10.944 · Cited by 3,078
Podschun, R., & Ullmann, U. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.4.589 · Cited by 2,688
Abagyan, R., Totrov, M., & Kuznetsov, D. (1994) · Journal of Computational Chemistry · doi:10.1002/jcc.540150503 · Cited by 1,699
Completing bacterial genome assemblies with multiplex MinION sequencing
Wick, R. R., Judd, L. M., Gorrie, C. L., & Holt, K. E. (2017) · Microbial Genomics · doi:10.1099/mgen.0.000132 · Cited by 978 · cited 1×
“INF348 was also subjected to long-read sequencing via Oxford Nanopore Technologies as previously described (49).”
MethodSelf-citationCarbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance
Pitout, J. D. D., Nordmann, P., & Poirel, L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01019-15 · Cited by 852
Gika, H. G., Theodoridis, G. A., Wingate, J. E., & Wilson, I. D. (2007) · Journal of Proteome Research · doi:10.1021/pr070183p · Cited by 502
Flexible protein–ligand docking by global energy optimization in internal coordinates
Totrov, M., & Abagyan, R. (1997) · Proteins: Structure, Function, and Genetics · doi:10.1002/(sici)1097-0134(1997)1+<215::aid-prot29>3.0.co;2-q · Cited by 407
Han, R., Shi, Q., Wu, S., Yin, D., Peng, M., Dong, D., Zheng, Y., Guo, Y., Zhang, R., Hu, F., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00314 · Cited by 386
Choi, U., & Lee, C.-R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00953 · Cited by 382 · cited 1×
“…with reduced susceptibility to carbapenems and cephalosporins in K. pneumoniae (30) and other Enterobacteriaceae (31, 32) and to nitrofurantoin in E. coli (33); however, we could not identify any prior reports of ompK36 / ompC mutations related to nitrofurantoin resistance in K. pneumoniae .”
BackgroundKarlowsky, J. A., Kelly, L. J., Thornsberry, C., Jones, M. E., & Sahm, D. F. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2540-2545.2002 · Cited by 367
Tsai, Y.-K., Fung, C.-P., Lin, J.-C., Chen, J.-H., Chang, F.-Y., Chen, T.-L., & Siu, L. K. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01275-10 · Cited by 344 · cited 1×
“The ompK36 gene encodes an outer membrane porin (homologous to E. coli ompC ) (28, 29) and was disrupted in five of the six resistant mutants (Table 1).”
BackgroundLivermore, D. M., Warner, M., Mushtaq, S., Doumith, M., Zhang, J., & Woodford, N. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.01.012 · Cited by 341
IDEOM: an Excel interface for analysis of LC–MS-based metabolomics data
Creek, D. J., Jankevics, A., Burgess, K. E. V., Breitling, R., & Barrett, M. P. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts069 · Cited by 337
Varani, A. M., Siguier, P., Gourbeyre, E., Charneau, V., & Chandler, M. (2011) · Genome Biology · doi:10.1186/gb-2011-12-3-r30 · Cited by 323
Krásný, L., & Gourse, R. L. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600423 · Cited by 302 · cited 1×
“Riboflavin metabolism is the main hub for the production of FMN and FAD which are employed as cofactors in a plethora of cellular flavoprotein enzymatic reactions (45, 46).”
BackgroundKey takeaways from the U.S. CDC’s 2019 antibiotic resistance threats report for frontline providers
Kadri, S. S. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004371 · Cited by 292
McOsker, C. C., & Fitzpatrick, P. M. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.suppl_a.23 · Cited by 268 · cited 1×
“The observed perturbations of aminoacyl-tRNA biosynthesis and purine metabolism are in line with the primary mode of bacterial killing instigated by the unstable nitrofur antoin metabolites, which involves disruption of bacterial DNA, RNA, and protein synthesis (14, 41–43).”
BackgroundDaikos, G. L., & Markogiannakis, A. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03553.x · Cited by 238
Whiteway, J., Koziarz, P., Veall, J., Sandhu, N., Kumar, P., Hoecher, B., & Lambert, I. B. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.21.5529-5539.1998 · Cited by 237 · cited 1×
“Modification or loss of NfsB is a well-known mech anism of nitrofurantoin resistance in E. coli , leading to inactivated or poor catalytic function, which in turn cripples the cells’ ability to reduce nitrofurantoin into its toxic intermediate compounds (22).”
BackgroundRace, P. R., Lovering, A. L., Green, R. M., Ossor, A., White, S. A., Searle, P. F., Wrighton, C. J., & Hyde, E. I. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409652200 · Cited by 222
Zenno, S., Koike, H., Kumar, A. N., Jayaraman, R., Tanokura, M., & Saigo, K. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.15.4508-4514.1996 · Cited by 208
Gorrie, C. L., Mirčeta, M., Wick, R. R., Judd, L. M., Lam, M. M. C., Gomi, R., Abbott, I. J., Thomson, N. R., Strugnell, R. A., Pratt, N. F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30717-6 · Cited by 194
Self-citationThe nature and epidemiology of OqxAB, a multidrug efflux pump
Li, J., Zhang, H., Ning, J., Sajid, A., Cheng, G., Yuan, Z., & Hao, H. (2019) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-019-0489-3 · Cited by 187 · cited 2×
“Overexpression of oqxAB has been previously reported to be involved in nitrofurantoin resistance in K. pneumoniae and has also been noted as a determinant of resistance to nitrofurantoin and other antimicrobials in E. coli and K. pneumoniae (25–27).”
BackgroundSelf-citationOmpK36-mediated Carbapenem resistance attenuates ST258 Klebsiella pneumoniae in vivo
Wong, J. L. C., Romano, M., Kerry, L. E., Kwong, H.-S., Low, W.-W., Brett, S. J., Clements, A., Beis, K., & Frankel, G. (2019) · Nature Communications · doi:10.1038/s41467-019-11756-y · Cited by 185
Homology modeling by the ICM method
Cardozo, T., Totrov, M., & Abagyan, R. (1995) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340230314 · Cited by 170
Overlapping riboflavin supply pathways in bacteria
García-Angulo, V. A. (2016) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2016.1192578 · Cited by 167 · cited 1×
“Riboflavin metabolism is the main hub for the production of FMN and FAD which are employed as cofactors in a plethora of cellular flavoprotein enzymatic reactions (45, 46).”
BackgroundParkinson, G. N., Skelly, J. V., & Neidle, S. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000159m · Cited by 157
ISMapper: identifying transposase insertion sites in bacterial genomes from short read sequence data
Hawkey, J., Hamidian, M., Wick, R. R., Edwards, D., Billman‐Jacobe, H., Hall, R. M., & Holt, K. E. (2015) · BMC Genomics · doi:10.1186/s12864-015-1860-2 · Cited by 150
Self-citationThe biosynthesis of nicotinamide adenine dinucleotides in bacteria
Begley, T. P., Kinsland, C. L., Mehl, R. A., Osterman, A. L., & Dorrestein, P. C. (2001) · Vitamins and hormones · doi:10.1016/s0083-6729(01)61003-3 · Cited by 143 · cited 1×
“The nicotinamide adenine dinucleotides (NAD + and NADP + ) are critical in generating the main components of coenzymes involved in redox reactions and for enabling electron transport (44).”
BackgroundProduction of riboflavin and related cofactors by biotechnological processes
Liu, S., Hu, W., Wang, Z., & Chen, T. (2020) · Microbial Cell Factories · doi:10.1186/s12934-020-01302-7 · Cited by 137 · cited 4×
“The ribC (riboflavin synthase) and ribB (3,4-dihydroxy 2-butanone 4-phosphate synthase) genes are involved in riboflavin biosynthesis, a universal precursor of FMN and flavin adenine dinucleotide (FAD) (36).”
BackgroundInfluentialVeleba, M., Higgins, P. G., González, G., Seifert, H., & Schneiders, T. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00456-12 · Cited by 117 · cited 2×
“OqxR is a transcriptional repressor of the oqxAB efflux pump, such that disruptions in oqxR are expected to result in de-repression of oqxAB and increased efflux (24).”
BackgroundClancy, C. J., Chen, L., Hong, J. H., Cheng, S., Hao, B., Shields, R. K., Farrell, A., Doi, Y., Zhao, Y., Perlin, D. S., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01069-13 · Cited by 110 · cited 1×
“It has previously been reported that an IS 5 insertion 37 bp upstream of ompK36 reduced its expression in K. pneumoniae ST258, resulting in resistance to carbapenems but not colistin (nitrofurantoin was not tested) (35).”
BackgroundLovering, A. L., Hyde, E. I., Searle, P. F., & White, S. A. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4653 · Cited by 110 · cited 2×
“The comparative sequence and structural alignments show that the aforementioned key amino acids in NfsB are identical between E. coli and the K. pneumoniae isolates in our study, indicating that these conserved amino acids are important for cofactor binding (Fig S1) (40).”
Chemotherapeutic properties of prominent nitrofurans
Chamberlain, R. E. (1976) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/2.4.325 · Cited by 84
Abagyan, R. A., Batalov, S., Cardozo, T. J., Totrov, M. M., Webber, J., & Zhou, Y. (1997) · Proteins Structure Function and Bioinformatics · Cited by 83
Plasmid-Mediated OqxAB Is an Important Mechanism for Nitrofurantoin Resistance in Escherichia coli
Ho, P., Ng, K.-Y., Lo, W.-U., Law, P. Y.-T., Lai, E. L.-Y., Wang, Y., & Chow, K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02156-15 · Cited by 82 · cited 1×
“Overexpression of oqxAB has been previously reported to be involved in nitrofurantoin resistance in K. pneumoniae and has also been noted as a determinant of resistance to nitrofurantoin and other antimicrobials in E. coli and K. pneumoniae (25–27).”
BackgroundMedeiros, A. A., O’Brien, T., Rosenberg, E. Y., & Nikaido, H. (1987) · The Journal of Infectious Diseases · doi:10.1093/infdis/156.5.751 · Cited by 78 · cited 2×
“Disruption of ompC homologs has been associated with reduced susceptibility to carbapenems and cephalosporins in K. pneumoniae (30) and other Enterobacteriaceae (31, 32) and to nitrofurantoin in E. coli (33); however, we could not identify any prior reports of ompK36 / ompC mutations related to nitrofurantoin resistan…”
BackgroundBreakage of bacterial DNA by nitrofuran derivatives.
McCalla, D. R., Reuvers, A. P., & Kaiser, C. (1971) · PubMed · Cited by 71
In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae
Berçot, B., Poirel, L., Dortet, L., & Nordmann, P. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr296 · Cited by 70
Kwong, J. C., Lane, C. R., Romanes, F., da Silva, A. G., Easton, M., Cronin, K., Waters, M. J., Tomita, T., Stevens, K., Schultz, M. B., et al. (2018) · PeerJ · doi:10.7717/peerj.4210 · Cited by 69
Yigit, H., Anderson, G. J., Biddle, J. W., Steward, C. D., Rasheed, J. K., Valera, L., McGowan, J. E., & Tenover, F. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3817-3822.2002 · Cited by 68 · cited 1×
“…homologs has been associated with reduced susceptibility to carbapenems and cephalosporins in K. pneumoniae (30) and other Enterobacteriaceae (31, 32) and to nitrofurantoin in E. coli (33); however, we could not identify any prior reports of ompK36 / ompC mutations related to nitrofurantoin…”
BackgroundPorins OmpC and PhoE of Escherichia coli as Specific Cell-surface Targets of Human Lactoferrin
Sallmann, F. R., Baveye, S., Pattus, F., Salmon, V., Branza, N., Spik, G., & Legrand, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16107 · Cited by 62
Nitrofurans: Revival of an “old” drug class in the fight against antibiotic resistance
Le, V. V. H., & Rakonjac, J. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009663 · Cited by 60
Sekyere, J. O. (2018) · Future Science OA · doi:10.4155/fsoa-2017-0156 · Cited by 58
Mizuno, T., & Mizushima, S.-I. (1986) · Journal of Bacteriology · doi:10.1128/jb.168.1.86-95.1986 · Cited by 50 · cited 1×
“INF348-06 harbored an IS 1 × 2 insertion 47 bp upstream of ompK36 , which is within the promoter region defined for E. coli ompC (34).”
BackgroundXu, Q., Jiang, J., Zhu, Z., Xu, T., Sheng, Z.-K., Ye, M., Xu, X., & Wang, M. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.06.004 · Cited by 50
Advantage and limitations of nitrofurantoin in multi-drug resistant Indian scenario
Laishram, S., & Veeraraghavan, B. (2015) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.167350 · Cited by 47
Vervoort, J., Xavier, B. B., Stewardson, A. J., Coenen, S., Godycki-Ćwirko, M., Adriaenssens, N., Kowalczyk, A., Lammens, C., Harbarth, S., Goossens, H., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03952-14 · Cited by 45 · cited 14×
“In conclusion, the Asp198Tyr and W46C mutations in NfsB are likely to negatively influence the binding to FMN and in particular the overall fold and stability of the enzyme itself.”
BackgroundInfluentialWan, Y., Mills, E. A., Leung, R. C.-Y., Vieira, A., Zhi, X., Croucher, N. J., Woodford, N., Jauneikaite, E., Ellington, M. J., & Sriskandan, S. (2021) · Microbial Genomics · doi:10.1099/mgen.0.000702 · Cited by 40
Hussein, M. H., Hu, X., Paulin, O. K. A., Crawford, S., Zhou, Q. T., Baker, M. A., Schneider‐Futschik, E. K., Zhu, Y., Li, J., & Velkov, T. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.08.008 · Cited by 33
Self-citationHussein, M. H., Allobawi, R., Levou, I., Blaskovich, M. A. T., Rao, G. G., Li, J., & Velkov, T. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040786 · Cited by 28
Self-citationMehta, R., Rivera, D. D., Reilley, D. J., Tan, D., Thomas, P. W., Hinojosa, A., Stewart, A. C., Cheng, Z., Thomas, C. A., Crowder, M. W., et al. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c00290 · Cited by 26
Mottaghizadeh, F., Shoja, H. M., Haeili, M., & Darban‐Sarokhalil, D. (2019) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2019.10.002 · Cited by 16
Hussein, M. H., Wong, L. J. M., Zhao, J., Rees, V. E., Allobawi, R., Sharma, R., Rao, G. G., Baker, M. A., Li, J., & Velkov, T. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.02.021 · Cited by 14
Self-citation[Nitrofurans: a modern treatment for uncomplicated urinary infections?].
Cahen, P., & Honderlick, P. (2000) · PubMed · Cited by 4
Research works printed but not linked: 5
- 10.4103/0255-0857.167350 · DOI
- 10.1128/AAC.02156-15 · DOI
- 10.1093/jac/33.suppl_a.23 · DOI · Paper page
- McCalla DR, Reuvers A, Kaiser C. 1971. Breakage of bacterial DNA by nitrofuran derivatives. Cancer Res 31:2184–2188.
- 10.1002/(sici)1097-0134(1997)1+<29::aid-prot5>3.3.co;2-4 · doi:10.1002/(sici)1097-0134(1997)1+<29::aid-prot5>3.3.co;2-4
Cited by
Ding, J., Yan, W., Zheng, R., Ma, M., & Jiang, L. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1691215 · Cited by 25
Khamari, B., & Bulagonda, E. P. (2024) · Medical Principles and Practice · doi:10.1159/000542330 · Cited by 23
“Repression of drug in fl ux leading to resistance [54, 69] rpoA - rpoB”
InfluentialTripartite Loops Reverse Antibiotic Resistance
Chowdhury, F. R., & Findlay, B. (2025) · Molecular Biology and Evolution · doi:10.1093/molbev/msaf115 · Cited by 3
“…(Jing et al. 2021; Gross et al. 2024); genes involved in carbon, amino acid, and vitamin metabolism: cra (Shimada et al. 2005), leuA (Somers et al. 1973), pdxH , and thiH (di Salvo et al. 2002; Kriek et al. 2007); and the ribosomal genes rsmG and rpsM (Hoang et al. 2004; Okamoto et al. 2007) (Fig.”
Cai, M., Wang, X., Lu, K., Zhou, B., Wei, L., & Cheng, X. (2025) · Food Chemistry X · doi:10.1016/j.fochx.2025.102205 · Cited by 2
“The use of nitro-containing drugs, including gastric medications such as ranitidine (Kim et al., 2024), antimicrobial agents such as metronidazole (Walsh et al., 2024), and antibiotics such as nitrofurantoin (Hussein et al., 2024), is common in clinical practice.”
Morgan, G. M., Kimbrough, J. H., Karr, M. H., Thompson, J. M., West, J., Castanheira, M., Arends, S. J. R., & Scangarella-Oman, N. E. (2026) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01832-25 · Cited by 1
“Inactivation of oqxR promotes oqxAB derepression and concomitant increases in MIC values for fluoroquinolones (68), nitrofurantoin (69), and chloramphenicol among other antimicrobials (70).”
Metadata
- Authors
- Hussein, M., Sun, Z., Hawkey, J., Allobawi, R., Judd, L. M., Carbone, V., Sharma, R., Thombare, V., Baker, M., Rao, G. G., Li, J., Holt, K. E., & Velkov, T.
- Affiliations
- Monash University (AU)
- The University of Melbourne (AU)
- AgResearch (NZ)
- University of North Carolina at Chapel Hill (US)
- University of Newcastle Australia (AU)
- London School of Hygiene & Tropical Medicine (GB)
- Corresponding author
- Holt, Kathryn E.
- Velkov, Tony
- ORCID
- Venue
- mSystems
- Publisher
- American Society for Microbiology
- Published
- 2024-01-23
- Volume
- 9
- Issue
- 1
- Pages
- e0097223-e0097223
- ISSN
- 2379-5077 (ISSN-L)
- PMC
- PMC10805014
- OpenAlex
- W4389558828
- Cited by
- 14
- References
- 59
- Citations by year
- 2026: 8 · 2025: 4 · 2024: 2
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- mSystems (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- NOVA (University of Newcastle Australia) (submittedVersion)
- Funders
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R01AI146241)
- Bill and Melinda Gates Foundation (OPP1175797)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Physical Sciences › Environmental Science › Pollution › Pharmaceutical and Antibiotic Environmental Impacts
- Keywords
- nitrofurantoin resistance, Klebsiella pneumoniae, nitroreductase, NfsB, efflux pump regulation, bacterial metabolome, drug resistance mechanisms, multidrug resistance, urinary tract infection, riboflavin metabolism, purine metabolism, aminoacyl-tRNA biosynthesis, pantothenate and CoA biosynthesis
- MeSH terms
- Anti-Bacterial Agents, Humans, Klebsiella Infections, Klebsiella pneumoniae, Nitrofurantoin, Nitroreductases, Riboflavin, RNA, Transfer, Urinary Tract Infections, Genomics, Drug Resistance, Multiple, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.